Publication: Increased risk of acute antibody-mediated rejection despite long-term compromised B cell repopulation after rituximab induction in blood group incompatible living-donor renal transplantation
dc.contributor.coauthor | Weimer, Rolf | |
dc.contributor.coauthor | Dietrich, Hartmut | |
dc.contributor.coauthor | Karakizlis, Hristos | |
dc.contributor.coauthor | Daniel, Volker | |
dc.contributor.coauthor | Suesal, Caner | |
dc.contributor.coauthor | Groene, Hermann-Josef | |
dc.contributor.coauthor | Padberg, Winfried | |
dc.contributor.coauthor | Opelz, Gerhard | |
dc.contributor.department | TIREX (Koç University Transplant Immunology Research Centre of Excellence) | |
dc.contributor.kuauthor | Süsal, Caner | |
dc.contributor.schoolcollegeinstitute | Research Center | |
dc.date.accessioned | 2025-03-06T21:00:40Z | |
dc.date.issued | 2024 | |
dc.description.indexedby | WOS | |
dc.description.publisherscope | International | |
dc.description.sponsoredbyTubitakEu | N/A | |
dc.description.sponsorship | This study was supported by Astellas and Novartis Pharma. ClinTrials.gov NCT01136395;EudraCT No.: 2009-012198-36. | |
dc.identifier.doi | 10.1097/01.tp.0001064864.26770.4c | |
dc.identifier.eissn | 1534-6080 | |
dc.identifier.issn | 0041-1337 | |
dc.identifier.issue | 9S | |
dc.identifier.quartile | Q1 | |
dc.identifier.uri | https://doi.org/10.1097/01.tp.0001064864.26770.4c | |
dc.identifier.uri | https://hdl.handle.net/20.500.14288/27942 | |
dc.identifier.volume | 108 | |
dc.identifier.wos | 1373740300022 | |
dc.keywords | Antibody-mediated rejection | |
dc.keywords | Rituximab induction | |
dc.keywords | B cell repopulation | |
dc.keywords | Blood group incompatibility | |
dc.keywords | Living-donor renal transplantation | |
dc.keywords | Immunosuppression | |
dc.language.iso | eng | |
dc.publisher | Lippincott Williams and Wilkins | |
dc.relation.ispartof | Transplantation | |
dc.subject | Immunology | |
dc.subject | Surgery | |
dc.subject | Transplantation | |
dc.title | Increased risk of acute antibody-mediated rejection despite long-term compromised B cell repopulation after rituximab induction in blood group incompatible living-donor renal transplantation | |
dc.type | Meeting Abstract | |
dspace.entity.type | Publication | |
local.contributor.kuauthor | Süsal, Caner | |
local.publication.orgunit1 | Research Center | |
local.publication.orgunit2 | TIREX (Koç University Transplant Immunology Research Centre of Excellence) | |
relation.isOrgUnitOfPublication | 29cd9ca5-6407-4582-92b6-788bc6f33efd | |
relation.isOrgUnitOfPublication.latestForDiscovery | 29cd9ca5-6407-4582-92b6-788bc6f33efd | |
relation.isParentOrgUnitOfPublication | d437580f-9309-4ecb-864a-4af58309d287 | |
relation.isParentOrgUnitOfPublication.latestForDiscovery | d437580f-9309-4ecb-864a-4af58309d287 |